FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BETAPACE
sotalol hydrochloride
LOE Approaching
Enterprise Therapeutics
ORAL · TABLET
documentedlife-threatening ventricular arrhythmias+2
1992
NDA30/100
BETAPACE AF
sotalol hydrochloride
LOE Approaching
Enterprise Therapeutics
ORAL · TABLET
documentedlife-threatening ventricular arrhythmias+2
2000
NDA30/100
BETAPRONE
propiolactone
LOE Approaching
Forest Devices
IRRIGATION · SOLUTION
rabies in all age groups
1959
NDA30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · OINTMENT
1983
NDA30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · LOTION
1983
NDA30/100
BETATREX
betamethasone valerate
LOE Approaching
TOPICAL · CREAM
1983
NDA30/100
BETAXON
levobetaxolol hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SUSPENSION/DROPS
2000
NDA30/100
BETIMOL
timolol
LOE Approaching
Thea Pharma
OPHTHALMIC · SOLUTION/DROPS
the treatment of elevated intraocular pressure in patients with ocular hypertensionopen-angle glaucoma+2
1995
SMNDA30/100
BETOPTIC
betaxolol hydrochloride
LOE Approaching
Novartis
OPHTHALMIC · SOLUTION/DROPS
the treatment of ocular hypertensionchronic open-angle glaucoma+3
1985
NDA30/100
BETOPTIC PILO
betaxolol hydrochloride; pilocarpine hydrochloride
LOE Approaching
Alcon
OPHTHALMIC · SUSPENSION/DROPS
elevated intraocular pressure in patients with primary open-angle glaucomaocular hypertension+2
1997
NDA30/100
BETOPTIC S
betaxolol hydrochloride
LOE Approaching
Novartis
OPHTHALMIC · SUSPENSION/DROPS
elevated intraocular pressure (IOP) in patients with chronic open-angle glaucomaocular hypertension+2
1989
NDA30/100
BEXTRA
valdecoxib
LOE Approaching
Pfizer
ORAL · TABLET
2001
SMNDA30/100
BIAXIN
clarithromycin
LOE Approaching
AbbVie
ORAL · FOR SUSPENSION
mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditionsGranules for Oral Suspension) Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment+13
1993
NDA30/100
BIAXIN
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET
mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditionsGranules for Oral Suspension) Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment+13
1991
NDA30/100
BIAXIN XL
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
mild to moderate infections caused by susceptible isolates due to Haemophilus influenzaeMoraxella catarrhalis+12
2000
NDA30/100
BIAXIN XL
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET
mild to moderate infections caused by susceptible isolates due to Haemophilus influenzaeMoraxella catarrhalis+12
1993
NDA30/100
BICILLIN
penicillin g benzathine
LOE Approaching
Thayer Medical
ORAL · SUSPENSION
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1951
NDA30/100
BICILLIN C-R
penicillin g benzathine and penicillin g procaine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infectionsthe treatment of the following in pediatric patients: Moderately severe to severe infections of the upper-respiratory tract+4
1953
NDA30/100
BICILLIN C-R 900/300
penicillin g benzathine and penicillin g procaine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infectionsthe treatment of the following in pediatric patients: Moderately severe to severe infections of the upper-respiratory tract+4
1953
NDA30/100
BICILLIN L-A
penicillin g benzathine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1952
NDA30/100
BICILLIN L-A
penicillin g benzathine
LOE Approaching
Thayer Medical
INJECTION · INJECTABLE
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1958
NDA30/100
BICNU
carmustine
LOE Approaching
INJECTION · INJECTABLE
glioblastomamyeloma+1
1977
NDA30/100
BIDIL
hydralazine hydrochloride and isosorbide dinitrate
LOE Approaching
R-Pharm US
ORAL · TABLET
heart failureto prolong time to hospitalization for heart failure+1
2005
NDA30/100
BILOPAQUE
tyropanoate sodium
LOE Approaching
ORAL · CAPSULE
1969
NDA30/100